Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2023, Cilt: 14 Sayı: 2, 215 - 220, 17.03.2023

Neriman Yükseltürk Şimşek , Semra Açıksöz , Nurdan Yalçın Atar

https://doi.org/10.31067/acusaglik.1109356

Öz

Kaynakça

  • 1. Kadali RAK, Janagama R. (2021). Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol.
  • 2. Hughes MM, Groenewold MR, Lessem SE, et al. Update: characteris-tics of health care personnel with COVID-19 - United States, February12 - July 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1364-68.
  • 3. Güngör, S., & Örün, E. (2020). SARS-CoV-2 Aşı Çalışmaları. YIU Saglik Bil Derg, 1, 42−47.
  • 4. Robertson, E.; Reeve, K.S.; Niedzwiedz, C.L.; Moore, J.; Blake, M.; Green, M.; Katikireddim, V.S.; Benzeval, J.M. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav. Immun. 2021, 94, 41–50.
  • 5. Brandt, E.J.; Rosenberg, J.; Waselewski, M.E.; Amaro, X.; Wasag, J.; Chang, T. National study of youth opinions on vaccination for COVID-19 in the U.S. J. Adolesc. Health 2021, 68, 869–872.
  • 6. Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., & Roser, M. (2020). Coronavirus pandemic (COVID-19). Our World in Data.
  • 7. Remmel A. (2021). COVID Vaccines and Safety: What the Research Says. Nature, 590, 538–40.
  • 8. El-Shitany, N.A., Harakeh, S., Badr-Eldin, S.M., Bagher, A.M., Eid, B., Almukadi, H., Alghamdi, B.S., Alahmadi, A.A., Hassan, N.A., Sindi, N., et al. (2021). moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: A retrospective cross-sectional study. Int. J. Gen. Med., 14, 1389–1401.
  • 9. Grech V, Gauci C, Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Hum Dev. 2020:105213.
  • 10. Adhikari, P., Adhikari, K., Gauli, B., Sitaula, D. (2021). Acceptance of covıd-19 vaccıne and pattern of sıde effects ın nepalese context: a post-vaccıne cross-sectıonal study among health care workers ın a tertıary care hospıtal. Journal of Chitwan Medical College, 11(36), 34-38
  • 11. Inbaraj, L.R., George, C.E., Franklyn, N.N. (2021). How safe is Covishield (ChAdOx1nCoV-19) Vaccine? Experience from a Tertiary Care Hospital in South India. Current Medical Issues, 19(3), 162-164.
  • 12. Abu-Hammad, O., Alduraidi, H., Abu-Hammad, S., Alnazzawi, A., Babkair, H., Abu-Hammad, A., & Dar-Odeh, N. (2021). Side Effects Reported by Jordanian HealthcareWorkers Who Received COVID-19 Vaccines. Vaccines, 9, 577.
  • 13. Polack FP, Thomas SJ, Kitchin N, et al. (2020). Safety and Efficacy of the BNT162b2 Mrna Covid-19 Vaccine. N Engl J Med, 383: 2603–2615.
  • 14. World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy The Strategic Advisory Group of Experts; World Health Organization: Geneva, Switzerland, 2020
  • 15. Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016; 34: 5013- 5020.
  • 16. Mohan, S.; Reagu, S.; Lindow, S.; Alabdulla, M. COVID-19 vaccine hesitancy in perinatal women: A cross sectional survey. J. Perinat. Med. 2021, 49, 678–685.
  • 17. Berenson, A.B.; Chang, M.; Hirth, J.M.; Kanukurthy, M. Intent to get vaccinated against COVID-19 among reproductive-aged women in Texas. Hum. Vaccin. Immunother. 2021, 17, 2914–2918.
  • 18. Mason, M. Why the Covid Vaccine Is Causing High Anxiety in Young Women. Forbes. 15 July 2021.
  • 19. Osborne-Crowley, L. There Is a Lot of Distrust: Why Women in Their 30s Are Hesitant about the Covid Vaccine. The Guardian. 30 January 2021.
  • 20. Kadoya, Y.; Watanapongvanich, S.; Yuktadatta, P.; Putthinun, P.; Lartey, S.T.; Khan, M.S.R. Willing or hesitant? A socioeconomic study on the potential acceptance of COVID-19 vaccine in Japan. J. Environ. Res. Public Health 2021, 18, 4864.
  • 21. Riad A, Sağıroğlu D, Üstün B, Attia S, Klugar M. Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study Among Healthcare Workers in Turkey. SSRN Electronic Journal. 2021. 10.2139/ssrn.3820571
  • 22. Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021. 10.1016/S1473-3099(21)00224-3.
  • 23. Song JY, Cheong HJ, Kim SR, Lee SE, Kim SH, Noh JY, et al. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers. J Korean Med Sci. 2021;36(15):e110.
  • 24. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebocontrolled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 2021;21(2):181-92.
  • 25. Zhang MX, Zhang TT, Shi GF, Cheng FM, Zheng YM, Tung TH, et al. Safety of an inactivated SARSCoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021:1-8
  • 26. Alabdulla M, Reagu SM, Al-khal A, Elzain M, Jones RM. (2021). COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional sur38 ISSN 2091-2889 (Online) ISSN 2091-2412 (Print) JCMC/ Vol 11/ No. 2/ Issue 36/ Apr- Jun, 2021 vey of a migrant-majority population. Influenza Other Respir Viruses, 15(3):361-70.

Determination of Early Side Effects After Covid-19 Vaccinations

Yıl 2023, Cilt: 14 Sayı: 2, 215 - 220, 17.03.2023

Neriman Yükseltürk Şimşek , Semra Açıksöz , Nurdan Yalçın Atar

https://doi.org/10.31067/acusaglik.1109356

Öz

Objectives: The first phase of the COVID-19 vaccine was launched in Turkey in January 2021 and was intended primarily for healthcare workers. Vaccine side effects play important role in building public confidence in vaccination. This study aims to determine the early-stage vaccine side effects in healthcare workers who have been given the COVID-19 vaccine.
Methods: The research has a descriptive cross-sectional type of design. The data were collected face-to-face with the questionnaire form created by the researchers, which investigated the sociodemographic characteristics and vaccine complications of the participants.
Results: The sample of the study consisted of 321 medical personnel (%55.6 female, %79.8 under 40 years, %67.1 nurses, %15.2 physicians, and %17.4 laboratory workers) who received the Covid-19 vaccine in Turkey and voluntarily agreed to participate in the study. The most common side effects associated with vaccination were as follows: pain (%46.3 Sinovac, %55.5 Pfizer- biotech), heat increase (%32.8 Sinovac, %30.7 Pfizer- biotech), whole-body aches (%55.2 Sinovac, %58.7 Pfizer- biotech) and injection site redness (%28.4 Sinovac, %26.0 Pfizer- biotech).
Conclusions: The benefits of the Covid-19 vaccine outweigh its identified side effects of it. Most of the side effects reported in this study were consistent with Pfizer-Biotech.

Anahtar Kelimeler

covid-19 vaccination side effect healtcare professional

Kaynakça

  • 1. Kadali RAK, Janagama R. (2021). Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol.
  • 2. Hughes MM, Groenewold MR, Lessem SE, et al. Update: characteris-tics of health care personnel with COVID-19 - United States, February12 - July 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1364-68.
  • 3. Güngör, S., & Örün, E. (2020). SARS-CoV-2 Aşı Çalışmaları. YIU Saglik Bil Derg, 1, 42−47.
  • 4. Robertson, E.; Reeve, K.S.; Niedzwiedz, C.L.; Moore, J.; Blake, M.; Green, M.; Katikireddim, V.S.; Benzeval, J.M. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav. Immun. 2021, 94, 41–50.
  • 5. Brandt, E.J.; Rosenberg, J.; Waselewski, M.E.; Amaro, X.; Wasag, J.; Chang, T. National study of youth opinions on vaccination for COVID-19 in the U.S. J. Adolesc. Health 2021, 68, 869–872.
  • 6. Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., & Roser, M. (2020). Coronavirus pandemic (COVID-19). Our World in Data.
  • 7. Remmel A. (2021). COVID Vaccines and Safety: What the Research Says. Nature, 590, 538–40.
  • 8. El-Shitany, N.A., Harakeh, S., Badr-Eldin, S.M., Bagher, A.M., Eid, B., Almukadi, H., Alghamdi, B.S., Alahmadi, A.A., Hassan, N.A., Sindi, N., et al. (2021). moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: A retrospective cross-sectional study. Int. J. Gen. Med., 14, 1389–1401.
  • 9. Grech V, Gauci C, Agius S. Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination. Early Hum Dev. 2020:105213.
  • 10. Adhikari, P., Adhikari, K., Gauli, B., Sitaula, D. (2021). Acceptance of covıd-19 vaccıne and pattern of sıde effects ın nepalese context: a post-vaccıne cross-sectıonal study among health care workers ın a tertıary care hospıtal. Journal of Chitwan Medical College, 11(36), 34-38
  • 11. Inbaraj, L.R., George, C.E., Franklyn, N.N. (2021). How safe is Covishield (ChAdOx1nCoV-19) Vaccine? Experience from a Tertiary Care Hospital in South India. Current Medical Issues, 19(3), 162-164.
  • 12. Abu-Hammad, O., Alduraidi, H., Abu-Hammad, S., Alnazzawi, A., Babkair, H., Abu-Hammad, A., & Dar-Odeh, N. (2021). Side Effects Reported by Jordanian HealthcareWorkers Who Received COVID-19 Vaccines. Vaccines, 9, 577.
  • 13. Polack FP, Thomas SJ, Kitchin N, et al. (2020). Safety and Efficacy of the BNT162b2 Mrna Covid-19 Vaccine. N Engl J Med, 383: 2603–2615.
  • 14. World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy The Strategic Advisory Group of Experts; World Health Organization: Geneva, Switzerland, 2020
  • 15. Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016; 34: 5013- 5020.
  • 16. Mohan, S.; Reagu, S.; Lindow, S.; Alabdulla, M. COVID-19 vaccine hesitancy in perinatal women: A cross sectional survey. J. Perinat. Med. 2021, 49, 678–685.
  • 17. Berenson, A.B.; Chang, M.; Hirth, J.M.; Kanukurthy, M. Intent to get vaccinated against COVID-19 among reproductive-aged women in Texas. Hum. Vaccin. Immunother. 2021, 17, 2914–2918.
  • 18. Mason, M. Why the Covid Vaccine Is Causing High Anxiety in Young Women. Forbes. 15 July 2021.
  • 19. Osborne-Crowley, L. There Is a Lot of Distrust: Why Women in Their 30s Are Hesitant about the Covid Vaccine. The Guardian. 30 January 2021.
  • 20. Kadoya, Y.; Watanapongvanich, S.; Yuktadatta, P.; Putthinun, P.; Lartey, S.T.; Khan, M.S.R. Willing or hesitant? A socioeconomic study on the potential acceptance of COVID-19 vaccine in Japan. J. Environ. Res. Public Health 2021, 18, 4864.
  • 21. Riad A, Sağıroğlu D, Üstün B, Attia S, Klugar M. Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study Among Healthcare Workers in Turkey. SSRN Electronic Journal. 2021. 10.2139/ssrn.3820571
  • 22. Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021. 10.1016/S1473-3099(21)00224-3.
  • 23. Song JY, Cheong HJ, Kim SR, Lee SE, Kim SH, Noh JY, et al. Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers. J Korean Med Sci. 2021;36(15):e110.
  • 24. Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebocontrolled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 2021;21(2):181-92.
  • 25. Zhang MX, Zhang TT, Shi GF, Cheng FM, Zheng YM, Tung TH, et al. Safety of an inactivated SARSCoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021:1-8
  • 26. Alabdulla M, Reagu SM, Al-khal A, Elzain M, Jones RM. (2021). COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional sur38 ISSN 2091-2889 (Online) ISSN 2091-2412 (Print) JCMC/ Vol 11/ No. 2/ Issue 36/ Apr- Jun, 2021 vey of a migrant-majority population. Influenza Other Respir Viruses, 15(3):361-70.
Toplam 26 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Halk Sağlığı, Çevre Sağlığı
Bölüm Research Article
Yazarlar

Neriman Yükseltürk Şimşek 0000-0002-4611-6661

Semra Açıksöz 0000-0003-0451-698X

Nurdan Yalçın Atar 0000-0002-6318-3882

Yayımlanma Tarihi 17 Mart 2023
Gönderilme Tarihi 26 Nisan 2022
Yayımlandığı Sayı Yıl 2023Cilt: 14 Sayı: 2

Kaynak Göster

EndNote Yükseltürk Şimşek N, Açıksöz S, Yalçın Atar N (01 Mart 2023) Determination of Early Side Effects After Covid-19 Vaccinations. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 2 215–220.
 Kapak Resmi İndir